Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Georgina Morley, PhD, MSc, RN and Annie Sharon Fox, MA
This series of 3 paintings of figures in a bath explores emotional responses of persons experiencing or responding to others’ moral distress. Intricately tied together and connected through time and space, the bodies represented suggest a complex web of relationships between clinicians and patients.
AMA J Ethics. 2019;21(5):E457-460. doi:
10.1001/amajethics.2019.457.
Correctional facilities’ physician employees are at risk for burnout, posttraumatic stress, and suicide. Prison reform should address needs of inmates and staff.
AMA J Ethics. 2019;21(6):E540-545. doi:
10.1001/amajethics.2019.540.
Concrete protocols for supporting trainees include convening team meetings, tracking bias incidents, collecting data, and initiating protective changes in culture.
AMA J Ethics. 2019;21(6):E513-520. doi:
10.1001/amajethics.2019.513.